Inventiva S.A. Made Headway
Wed, May 31, 2023 at 07:47 PM
Inventiva S.A. (IVA:NASDAQ) soared at $3.95, representing a gain of 31.5%. On Wed, May 31, 2023, IVA:NASDAQ touched a New 2-Week High of $3.95. The stock got featured on our News Catalysts scanner on Thu, May 25, 2023 at 04:37 PM in the 'BIOTECH' category. From Wed, May 17, 2023, the stock recorded 55.56% Up Days and 60.00% Green Days
About Inventiva S.A. (IVA:NASDAQ)
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation.
Top 10 Gainers:
- SunCar Technology Group Inc Ord (SDA:NASDAQ), 120.88%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 114.81%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 34.85%
- Inventiva S.A. (IVA:NASDAQ), 31.5%
- VIQ Solutions Inc. (VQS:NASDAQ), 28.76%
- Peak Bio Inc Com (PKBO:NASDAQ), 26.41%
- Bright Green Corporation (BGXX:NASDAQ), 24.01%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 22.96%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 22.88%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 22.59%